Janux Therapeutics, Inc.
JANX
$13.83
-$0.22-1.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 966.57M | 988.99M | 996.01M | 1.01B | 1.03B |
| Total Receivables | 6.43M | 6.32M | 5.69M | 5.59M | 5.38M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.89M | 2.78M | 3.85M | 3.61M | 3.11M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 975.89M | 998.09M | 1.01B | 1.02B | 1.03B |
|
|
|||||
| Total Current Assets | 975.89M | 998.09M | 1.01B | 1.02B | 1.03B |
| Net Property, Plant & Equipment | 22.25M | 23.24M | 23.15M | 23.83M | 24.15M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.42M | 3.44M | 3.51M | 3.61M | 3.70M |
| Total Assets | 1.00B | 1.02B | 1.03B | 1.05B | 1.06B |
|
|
|||||
| Total Accounts Payable | 4.97M | 3.40M | 3.48M | 2.35M | 4.03M |
| Total Accrued Expenses | 17.63M | 22.16M | 16.03M | 13.34M | 11.68M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.39M | 2.28M | 1.87M | 1.81M | 1.75M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 25.00M | 27.83M | 21.38M | 17.50M | 17.46M |
|
|
|||||
| Total Current Liabilities | 25.00M | 27.83M | 21.38M | 17.50M | 17.46M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 19.75M | 20.38M | 20.32M | 20.80M | 21.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 44.74M | 48.21M | 41.70M | 38.30M | 38.74M |
|
|
|||||
| Common Stock & APIC | 1.30B | 1.29B | 1.28B | 1.27B | 1.26B |
| Retained Earnings | -351.38M | -319.44M | -295.12M | -261.27M | -237.76M |
| Treasury Stock & Other | 4.32M | 4.56M | 3.75M | 3.76M | 2.16M |
| Total Common Equity | 956.82M | 976.56M | 990.52M | 1.01B | 1.02B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 956.82M | 976.56M | 990.52M | 1.01B | 1.02B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 956.82M | 976.56M | 990.52M | 1.01B | 1.02B |
|
|
|||||